Martha Rodriguez

Martha Rodriguez

Auto-generated profile, based on publicly available information

Martha Rodriguez

Department of Pediatric Rheumatology, Indiana University School of Medicine, Riley Hospital for Children, Indianapolis, IN, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in Open Access Rheumatology: Research and Reviews
Verified
Journal Article
Open access
PDF file
DFDanielle Fair
Danielle Fair
MRMartha Rodriguez
Martha Rodriguez
AKAndrea M Knight
Andrea M Knight
TRTamar B Rubinstein
Tamar B Rubinstein
Depression and anxiety are prevalent in children with rheumatologic diseases, including juvenile idiopathic arthritis (JIA). However, prevalence rates and the relationship with disease outcomes, including quality of life are conflicting in the early literature. To review the current literature, determine gaps in our knowledge, and identify areas in need of further investigation, we conducted a systematic review of studies examining depression and anxiety symptoms among children with JIA and the impact these symptoms may have on disease outcomes and quality of life. Six electronic databases were searched up until January 2019. Of 799 potential articles, 60 articles were included with the main focus on 28 articles from 2009 to 2019, to concentrate on the most current evidence. We found that JIA patients experience symptoms of depression and anxiety similar to other childhood chronic diseases and at higher rates than in healthy children. Patients who experience these symptoms have worse quality of life, with some evidence pointing to depression and anxiety symptoms having a greater impact on quality of life than other disease features, such as active joint count. Family members of JIA patients experience high rates of anxiety and depression symptoms which may impact their child’s mental health and pain symptoms related to JIA. Conflicting reports of associations between depression/anxiety symptoms and disease features/disease outcomes and a paucity of longitudinal studies investigating the impact of treatment on mental health symptoms indicate areas in need of further research to effectively identify patients at greatest risk of depression and anxiety and to better understand how to treat and prevent these symptoms in youth with JIA. Family mental health should also be considered in investigations concerning mental health and disease outcomes of children with JIA.

19 September 2016 in Pharmacogenomics
Verified
Journal Article
Closed access
KMKatie A McCrink
Katie A McCrink
ABAva Brill
Ava Brill
MJMalika Jafferjee
Malika Jafferjee
TVThairy Reyes Valero
Thairy Reyes Valero
CMChristine Marrero
Christine Marrero
Anastasios LymperopoulosAnastasios Lymperopoulos
Anastasios Lymperopoulos
Aim: The β1-adrenergic receptor (AR) Arg389Gly polymorphism affects efficacy of its procontractile signaling in cardiomyocytes and carriers’ responses to β-blockers. To identify molecular mechanisms underlying functional differences between Arg389 and Gly389 β1ARs, we examined their binding to β-arrestins (βarr-1 and -2), which mediate β1AR signaling, in neonatal rat ventricular myocytes. Methods: We tested the β1AR–βarr interaction via β1AR immunoprecipitation followed by βarr immunoblotting. Results: βarr1 binds both variants upon isoproterenol, carvedilol or metoprolol treatment in neonatal rat ventricular myocytes. Conversely, the potentially beneficial in the heart βarr2 only interacts with the Arg389 receptor in response to isoproterenol or carvedilol. Conclusion: Arg389 confers unique βarr2-interacting tropism to the β1AR in cardiac myocytes, potentially underlying this variant's gain-of-function phenotype and better clinical responses to β-blockers.

1 September 2026 in Open Access Rheumatology: Research and Reviews
Verified
Journal Article
Open access
PDF file
ATAlexandra Theisen
Alexandra Theisen
EOEkemini A. Ogbu
Ekemini A. Ogbu
EBEmily F Beil
Emily F Beil
OHOnengiya Harry
Onengiya Harry
SASimone Appenzeller
Simone Appenzeller
MRMartha Rodriguez
Martha Rodriguez
Background: Neuropsychiatric systemic lupus erythematosus (NPSLE) presents significant diagnostic and therapeutic challenges, particularly in childhood-onset SLE (cSLE), as there is limited pediatric-specific evidence, lack of specific diagnostic tests, and heavy reliance on adult data. This scoping review, the first dedicated specifically to the pediatric population, aims to evaluate the current literature on NPSLE in cSLE (cNPSLE), grade the level of evidence, and identify knowledge gaps in knowledge related to its manifestations, diagnosis, predictors, treatment and outcomes. Methods: A search was performed in MEDLINE, Embase, Cochrane, and PsycINFO (PRISMA diagram). Articles were screened in Covidence. Clinical trials, systematic reviews, cohort, case-control and cross-sectional studies published between 2000 and 2023, involving patients aged ≤ 18 years diagnosed with NPSLE, and with original manuscript available in English were included. Five reviewers performed abstract and full-text screening. Eight reviewers performed full-text extraction. Quality of evidence was assessed using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) methodology. Results: Sixty-five articles met eligibility criteria. Prevalence of cNPSLE ranged from 4.4% to 99.8%. Sociodemographic information was based on individual study metrics. Predictive factors for cNPSLE development were the most studied but were contradictory from study to study. Most frequent clinical manifestations were cognitive dysfunction, headaches and seizures. Common imaging findings were cerebral and cerebellar volume loss and white matter hyperintensities, though up to 50% of patients with active cNPSLE had normal imaging in 4 included studies. No pharmacologic clinical trials for cNPSLE are published. Outcomes from cNPSLE were variable. Conclusion: This scoping review highlights the scarcity of articles on cNPSLE and identifies significant knowledge gaps. The 1999 ACR NPSLE case definitions, while providing a framework for classifying NPSLE, are not formally validated in children, resulting in heterogeneity in existing cNPSLE research and diagnostic criteria. Per the GRADE methodology, most studies were retrospective, single center, with low quality of evidence. The range in prevalence and frequency of cNPSLE manifestations highlights the lack of consensus in cNPSLE definition and evaluation as well as the heterogeneity of study populations. We highlight the need for high quality studies and consensus regarding cNPSLE definition, diagnosis, and management – a critical first step to guide the development of an international, multi-center prioritized research agenda for cNPSLE.